生物医药系列产品
数据
资源
版本对比
免费注册
预约演示
免费注册
Novel Research by
PAX
and
Zentrela
Suggests Cannabis “Entourage Effect,” Not THC Potency, Responsible for Psychoactive Experience
2023-10-03
·
BioSpace
临床结果
Electroencephalogram (EEG) Study Demonstrates How Full Spectrum Cannabis Can Deliver Faster Onset and More Than Twice the Psychoactive Effects SAN FRANCISCO--(BUSINESS WIRE)--
PAX
, a leading global cannabis brand, today announced a collaboration with pioneering Canadian neurotechnology company,
Zentrela
, leveraging brainwave research to provide consumers with data-driven insight into cannabis effects — ultimately supporting more informed purchasing and consumption decisions. This press release features multimedia. View the full release here: Full Spectrum Cannabis Can Deliver Faster Onset and More Than Twice the Psychoactive Effects (Graphic: Business Wire) This original study, EEG-based analysis for quantifying the psychoactive effects, including onset time and maximum strength, of
PAX
’s Live Rosin with Natural Diamonds and High Purity THC Cannabis Products by Upmanyu Sharma, Israel Gasperin Haaz, Dr. Dan Bosnyak, Ricardo Zelidon, Dr. David Faulkner, and Dr. Echo Rufer, showcased meaningful insights into the cannabis experience. Key findings suggest that whole plant, full spectrum products can produce a statistically significant faster onset and more than double the psychoactive experience than distillate products with comparable
Delta-9-tetrahydrocannabinol
(THC) potencies due to the “entourage effect,” or presence of additional whole plant compounds like phytocannabinoids and terpenes. “Consumers looking for psychoactive effects typically shop for cannabis products based on THC, which is a bit of a fallacy,” said Brian Witlin, VP of Product Development at
PAX
. “In the spirit of continuing to advance cannabis research and understanding of the plant — which has been far too limited for much too long — we wanted to demonstrate through scientific study how full spectrum products with the full range of terpenes and cannabinoids have a more profound impact on the onset and ultimate cannabis experience. We hope this type of insight helps consumers understand that shopping for products based on THC% alone is not the leading indicator of expected experience.” “Our mission at
Zentrela
,” said company founder and CEO Israel Gasperin, “is to help consumers better understand the experiences that cannabis products create.
PAX
is a great partner because we share a dedication to innovation and a commitment to use the most advanced scientific research techniques to expand our understanding of cannabis effects.” This study compared two distinct, inhalable cannabis products with similar THC potencies, focusing on
PAX
Live Rosin with Natural Diamonds in Blue Dream — a full spectrum live rosin-based product which preserves natural cannabinoids and terpenes, and
PAX
High Purity THC in Berry Gelato — a distillate-based product. The study involved 28 participants who consumed cannabis vapor from a
PAX
Era Pro device.
Zentrela
's non-invasive portable EEG device recorded data from eight brain regions, both before and after product consumption. Cognalyzer® AI-based EEG analysis uses machine learning on large EEG datasets to detect specific brainwave changes and was employed to convert EEG data into psychoactive effect levels (PEL) on a standardized scale.
PAX
is a leading global cannabis brand on a mission to enhance people’s lives, delivering well-being through consistent quality, memorable experiences and a genuine passion for the plant. For more than a decade,
PAX
has provided products that are simple, enjoyable, and trusted by millions.
PAX
has been recognized for its brand, culture and products by The New York Times’ Wirecutter, TIME, Fast Company, GQ, Gear Patrol, mg Magazine, High Times, and many more.
PAX
is committed to making a positive impact through PEACE BY
PAX
, its purpose-driven platform supporting social reform, safe access and sustainability.
Zentrela
is an independent research organization that utilizes novel non-invasive neurotechnology to accurately and objectively quantify and classify the effects cannabis products create for consumers. With a mission to become the most trusted and comprehensive provider of cannabis product effect information,
Zentrela
is dedicated to empowering consumers with the knowledge they need to make informed consumption decisions. © 2023
PAX Labs, Inc.
All Rights Reserved.
PAX
, X, and ERA are all trademarks of
PAX Labs, Inc.
Patents and Trademarks: pax.com/IP.
更多内容,
请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
机构
JUUL Labs, Inc.
Zentrela Inc
Pax Labs, Inc.
适应症
-
靶点
-
药物
屈大麻酚
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
来和芽仔聊天吧
热门报告
特应性皮炎深度解析:药物开发、专利分析与风险评估
智慧芽生物医药
2024年7月全球首批及特殊审评药物报告
智慧芽生物医药
GPRC5D靶点专利调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务